Flagship Harbor Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-216
Closed -$44.6K 1188
2025
Q4
$44.6K Buy
+216
New +$43.2K ﹤0.01% 1104
2021
Q1
Sell
-5,710
Closed -$959K 637
2020
Q4
$959K Buy
5,710
+5,200
+1,020% +$844K 0.12% 184
2020
Q3
$80K Sell
510
-373
-42% -$61K 0.01% 716
2020
Q2
$148K Buy
883
+233
+36% +$36.6K 0.02% 534
2020
Q1
$85K Sell
650
-50
-7% -$7.12K 0.02% 596
2019
Q4
$104K Sell
700
-239
-25% -$32.8K 0.02% 604
2019
Q3
$116K Sell
939
-164
-15% -$21.8K 0.02% 543
2019
Q2
$155K Sell
1,103
-544
-33% -$75.1K 0.03% 459
2019
Q1
$248K Hold
1,647
0.05% 350
2018
Q4
$204K Buy
1,647
+522
+46% +$71.4K 0.05% 345
2018
Q3
$177K Buy
1,125
+100
+10% +$15.1K 0.03% 447
2018
Q2
$143K Buy
+1,025
New +$141K 0.03% 475
2017
Q2
Sell
-2,211
Closed -$223K 347
2017
Q1
$223K Sell
2,211
-383
-15% -$38.4K 0.09% 270
2016
Q4
$243K Buy
+2,594
New +$243K 0.1% 227

Other funds holding FBT

Flagship Harbor Advisors's FBT Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2026, closing a stake of 216 shares — an estimated $44.6K sold.

Flagship Harbor Advisors first reported a position in FBT in Q4 2016 and held it in 14 quarters. The position peaked at $959K in Q4 2020. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 216 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $44.6K.
  • Flagship Harbor Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2016 and held it in 14 quarters.
  • Flagship Harbor Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $959K in Q4 2020.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.